Lunit to Highlight New AI Evidence in Cancer Screening and Breast Density–Driven Risk Modeling at RSNA 2025
Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and density-informed risk modeling December 3, 2025 — Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced… Read More »Lunit to Highlight New AI Evidence in Cancer Screening and Breast Density–Driven Risk Modeling at RSNA 2025





